Project reference | Status | Initial Date | Current Stage | Next Stage | Forecasted voting date |
---|
EN ISO 10993-12:2021/prA1 (WI=00206102) Biological evaluation of medical devices - Part 12: Sample preparation and reference materials - Amendment 1 (ISO 10993 12:2021/DAM 1:2024) | Under Approval | 2023-11-01 | 2024-09-11 | 2025-05-12 | 2025-05-12 |
EN ISO 10993-17:2023/prA1 (WI=00206106) Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/DAmd 1:2024) | Under Approval | 2023-11-01 | 2024-10-23 | 2025-06-23 | 2025-06-23 |
EN ISO 10993-23:2021/prA1 (WI=00206105) Biological evaluation of medical devices - Part 23: Tests for irritation - Amendment 1: Additional in vitro reconstructed human epidermis models (ISO 10993-23:2021/DAmd1:2024) | Under Approval | 2023-11-01 | 2024-12-18 | 2025-08-18 | 2025-08-18 |
EN ISO 10993-4:2017/prA1 (WI=00206099) Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood - Amendment 1 (ISO 10993-4:2017/DAmd 1:2024) | Under Approval | 2023-04-19 | 2024-10-07 | 2025-01-13 | 2024-10-07 |
EN ISO 10993-5:2009/prA11 (WI=00206109) Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Under Drafting | 2024-08-19 | 2024-08-19 | 2024-12-19 | 2026-05-27 |
prEN ISO 10993-1 (WI=00206092) Biological evaluation of medical devices - Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process (ISO/DIS 10993-1:2024) | Under Approval | 2022-01-14 | 2024-09-16 | 2025-05-16 | 2025-05-16 |
prEN ISO 10993-11 rev (WI=00206098) Biological evaluation of medical devices — Part 11: Tests for systemic toxicity | Under Drafting | 2023-04-19 | 2023-04-19 | 2023-10-19 | 2025-05-27 |
prEN ISO 10993-13 rev (WI=00206112) Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices | Under Drafting | 2024-10-31 | 2024-10-31 | 2025-04-30 | 2026-12-09 |
prEN ISO 10993-14 rev (WI=00206113) Biological evaluation of medical devices — Part 14: Identification and quantification of degradation products from ceramics | Under Drafting | 2024-10-31 | 2024-10-31 | 2025-04-30 | 2026-12-09 |
prEN ISO 10993-16 rev (WI=00206103) Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables | Under Drafting | 2023-11-01 | 2023-11-01 | 2024-05-02 | 2025-12-15 |
prEN ISO 10993-2 (WI=00206104) Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO/DIS 10993-2:2024) | Under Enquiry | 2023-11-01 | 2024-11-14 | 2025-02-03 | 2025-10-03 |
prEN ISO 10993-3 rev (WI=00206101) Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity | Under Drafting | 2023-11-01 | 2023-11-01 | 2024-05-02 | 2025-12-15 |
prEN ISO 10993-4 rev (WI=00206111) Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood | Under Drafting | 2024-10-31 | 2024-10-31 | 2025-04-30 | 2026-12-09 |
prEN ISO 10993-6 (WI=00206097) Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO/DIS 10993-6:2024) | Under Approval | 2023-01-06 | 2024-08-13 | 2025-04-14 | 2025-04-14 |
prEN ISO 10993-7 (WI=00206093) Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO/DIS 10993-7:2024) | Under Approval | 2022-03-22 | 2024-12-06 | 2025-03-14 | 2024-12-06 |
prEN ISO 14155 (WI=00206095) Clinical investigation of medical devices for human subjects - Good clinical practice (ISO/DIS 14155:2024) | Under Approval | 2022-12-12 | 2024-09-12 | 2025-05-12 | 2025-05-12 |
| Under Drafting | 2023-01-16 | 2023-01-16 | 2023-07-17 | 2025-02-26 |
prEN ISO 21762 (WI=00206100) Medical devices utilizing human tissues and their derivatives -- Application of risk management | Under Drafting | 2023-10-12 | 2023-10-12 | 2024-04-12 | 2025-11-27 |
prEN ISO 22442-3 rev (WI=00206110) Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents | Under Drafting | 2024-10-31 | 2024-10-31 | 2025-04-30 | 2026-12-09 |
prEN ISO 8250 (WI=00206114) Cleanliness of medical devices - Process design and test methods | Under Drafting | 2024-11-28 | 2024-11-28 | 2025-05-28 | 2027-01-08 |